Search for the latest oncology news by tumour type
ASH 2023: Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma
Researchers conducting a Phase 2 clinical trial at Sylvester Comprehensive Cancer Center at the University…